Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Soc.Bol SIBE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Faes Farma SA

+ Add to Watchlist

FAE:SM

2.1500 EUR 0.0050 0.23%

As of 07:30:06 ET on 03/03/2015.

Snapshot for Faes Farma SA (FAE)

Open: 2.1650 Day's Range: 2.1400 - 2.1700 Volume: 243,553
Previous Close: 2.1550 52wk Range: 1.6450 - 2.4950 1-Yr Rtn: -4.82%

Stock Chart for FAE

No chart data available.
  • FAE:SM 2.1500
  • 1D
  • 1M
  • 1Y
2.1550
Interactive FAE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FAE

Current P/E Ratio (ttm) 16.8254
Estimated P/E(12/2015) 16.6667
Relative P/E vs. IBEX 0.7090
Earnings Per Share (EUR) (ttm) 0.1278
Est. EPS (EUR) (12/2015) 0.1290
Est. PEG Ratio -
Market Cap (M EUR) 522.57
Shares Outstanding (M) 243.05
30 Day Average Volume 418,851
Price/Book (mrq) 3.1863
Price/Sale (ttm) 2.1791
Dividend Indicated Gross Yield 4.42%
Cash Dividend (EUR) 0.0514
Dividend Ex-Date 12/15/2014
5 Year Dividend Growth 4.70%
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FAE

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for FAE

Faes Farma, S.A. develops, manufactures and markets pharmaceutical products throughout Spain and, through its subsidiary, Laboratorios Vitoria S.A., in Portugal. The Company's principal prescription products combat cardiovascular, respiratory, central nervous system, musculoskeletal and osteoporosis related ailments.

Mariano Ucar AnguloChairmanFrancisco Quintanilla GuerraGeneral Director
Gonzalo Lopez CasanuevaGeneral DirectorValentin Ruiz UnamunzagaDeputy Gen Dir/CFO
More Company Profile & Key Executives for FAE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil